Dark

GILD
Gilead Sciences Inc
stock NASDAQ

At Close

Jul 27, 2026 3:59:56 PM EDT

130.49USD+0.909%(+1.18)4,925,621

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 27, 2026 9:22:30 AM EDT

130.70USD+1.075%(+1.39)1,205

After-hours

Jul 27, 2026 4:21:30 PM EDT

130.58USD+0.073%(+0.09)1,152,686

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

162.01B

Headquarters

Foster City, California, USA

Industry

Drug Manufacturers-General

Next Earnings

Aug 4, 2026 (7d)

Last Dividend

Jun 15, 20260.820

Last Split

Jan 28, 20132for1

AMGN ALXN CELG VRTX ILMN BIIB JNJ LLY MRK ABBV XLV

GILD Stats

Avg. Vol. 10 Day

5,868,921

Avg. Vol. 30 Day

7,700,767

Employees

10,000

Market Cap

162,012,452,858

Shares Out.

1,241,569,874

On/Off Exchange

61%/39%

6 Month Beta

0.32

1 Year Beta

0.31

2 Year Beta

0.36

3 Year Beta

0.34

52 Week Low

108.46

52 Week High

157.29

SMA50

129.65

SMA200

131.41

1 Week

-2.04%

1 Month

+2.04%

3 Month

+2.15%

6 Month

-7.43%

1 Year

+15.45%

2 Year

+69.45%

5 Year

+89.31%

Profile

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

GILD Stock Summary

Gilead Sciences Inc (NASDAQ:GILD) stock price today is $130.49, and today's volume is 4,925,621. GILD is up 0.909% today. The 30 day average volume is 7,700,767. GILD market cap is 162.01B with 1,241,569,874 shares outstanding.

document.getElementById("Q72Z4R").onerror = function(){this.style.display='none';}; .dark-mode .XyKbpJ{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .XyKbpJ{ color: #333333; background-color: white; border: 2px solid #333333; }GILDGilead Sciences Incstock NASDAQ

GILD Stock Summary

GILD
Gilead Sciences Inc
stock NASDAQ